QIAGEN powered by

Oncology Solid Tumors

Empowering clinicians to deliver more personalized healthcare

Precision medicine requires precision in clinical interpretation and reporting. With QIAGEN Clinical Insights (QCI) Interpret for Oncology, your lab gains access to the most clinically relevant and up-to-date information, drastically reducing your curation time. The intuitive software produces concise, actionable reports that accelerates your clinicians’ ability to deliver the best treatment options for their patients.

Live Webinar on March 7

Join Dr. Marie-Laure Yaspo, Co-Founder and Chief Scientific Officer of Alacris Theranostics, as she discusses the application and analysis of the Comprehensive Molecular Tumor Analysis (CMTA) using QCI Interpret for Oncology.

Actionable reports for simplified decison-making

QCI nterpret for Oncology interprets a cancer patient’s genetic data, building a personalized report that informs the oncologist of which genetic mutations are likely causing the cancer, which precision therapies are known to work against these mutations, and where the patient can go to access these treatments or trials.

Munich Leukemia Laboratory selects QCI Interpret for NGS solid tumor testing

Munich Leukemia Laboratory, one of the world’s largest leukemia laboratories, has selected QCI Interpret for Oncology to support the analysis, interpretation, and reporting of Illumina’s TruSight Oncology 500 Assay, a comprehensive genomic profiling test for solid tumors.

Munich Leukemia Laboratory Quote

Solutions for oncology NGS testing

QCI Interpret One

Clinical decision support software with professional services

QCI Precision Insights

Professional variant interpretation service for oncology NGS testing

QCI Interpret

Clinical decision support software for oncology NGS testing

Interested in our multimodal NGS panels?

Learn more about QIAGEN’s QIAseq Multimodal Panels for comprehensive genomic profiling of solid tumors and hematological malignancies.